The New Antiretroviral Arsenal Article

The New Antiretroviral Arsenal Article

Antiretroviral agents

Combination Antiretroviral Therapy

Reverse transcriptase inhibitors

Protease inhibitors

AIDS (Disease)

HIV (Viruses)

HIV/AIDS

AIDS information centres

AIDS education

Medication

Article entitled "The New Antiretroviral Arsenal" by Denny Smith, AIDS Treatment News #259 (published twice monthly).

[Information acquired from another source:
Date: 15 November 1996.
Subscription and Editorial Office: P.O. Box 411256 San Francisco, CA 94141. Editor and Publisher: John S. James]

First page (pg 4) discusses drugs approved to treat HIV infection. Reverse Transcriptase Inhibitors. Lists AZT (aka. zidovudine; brand name: Retrovir), ddI (aka. didanosine; brand name: Videx), ddC (aka. zalcitabine; brand name: HIVID), d4T (aka. stavudine; brand name: Zerit), and 3TC (aka. lamivudine; brand name: Epirvir).

Page 4-5: Non-Nuceloside Reverse Transcriptase Inhibitors. Lists Nevirapine (brand name: Viramune).

Page 5: Delavirdine (aka Rescriptor). Protease Inhibitors. Indinavir (brand name: Crixivan), Ritonavir (brand name: Norvir), Saquinavir (brand name: Invirase), and Nelfinavir (brand name: Viracept). Miscellaneous. Hydroxyurea (brand name: Hydrea)

AIDS Treatment News

Arthur Leahy Collection

1996-11-15

Digitising these community resources in a publicly accessible digital archive can be seen as fair dealing and reasonable use of these materials (as defined in the 2000 Irish Copyright Act) and in keeping with the ethos and purpose with which they were produced. In addition to this, Permission to Use has also been granted by the owners of the collections and by the relevant community organisations. Items in this digital archive are covered by a Creative Commons Attribution Non-commercial No-Derivatives License. Please credit Cork LGBT Archive and provide a link back to this site.

application/pdf

eng

articles (documents)

Text

2017.21.5.1.566

1996